Feds secure $372M from lab testing scheme that targeted Medicare

The Justice Department has obtained $372 million in judgments against Kentucky businessman Rajen Shah and his companies for a laboratory testing scheme that targeted Medicare. 

A complaint-in-intervention filed in August 2022 alleged that Mr. Shah violated the False Claims Act by causing his labs to bill Medicare for expensive molecular tests that were not ordered by a medical provider. The following companies that Mr. Shah owns were also named in the complaint: United Diagnostics Lab, Tomoka Medical Lab, Tennessee Valley Regional Laboratory, Luminus Diagnostics and Golden Rule Management. 

A district court on Sept. 21, 2023, granted the federal government's motion for default judgment, awarding judgment in favor of the U.S. and against the defendants in the amount of:

- $105.6 million for Mr. Shah
- $6.2 million for Tomoka Medical Lab
- $24 million for Tennessee Valley Regional Laboratories
- $75.5 million for Luminus Diagnostics
- $105.6 million for Golden Rule Management 
- $54.6 million for United Diagnostics Lab

Mr. Shah received a prison sentence in 2021 for a criminal contempt charge stemming from his violation of court orders related to the fraud investigation. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

>